Literature DB >> 6705733

Characterization of the calf uterine progesterone receptor and its stabilization by nucleic acids.

G Theofan, A C Notides.   

Abstract

The molecular and steroid hormone-binding properties of the calf uterine progesterone receptor and its interaction with nucleic acids were investigated. A positive cooperative binding interaction of [3H]progesterone with the receptor was evident from a nonlinear Scatchard plot and a Hill coefficient of 1.22 +/- 0.02. The range of progesterone receptor concentrations was 0.73-1.04 pmol/mg protein, approximately twice that of the estrogen receptor. Competitive binding assays revealed a high specificity for progesterone: R5020 greater than or equal to progesterone greater than deoxycorticosterone greater than 5 alpha-pregnane-3,20-dione much greater than 17 alpha-hydroxyprogesterone greater than or equal to 20 alpha-dihydroprogesterone greater than or equal to testosterone greater than or equal to estradiol greater than cortisol. Thus, a progesterone-specific receptor of high affinity and concentration is obtainable from calf uterus in large quantities without estrogen pretreatment. Thermal inactivation of the unoccupied progesterone receptor is inhibited by 10 mM sodium molybdate, whereas thermal inactivation of the ammonium sulfate-purified progesterone receptor is not. Thermal inactivation of the ammonium sulfate-purified receptor is inhibited by nucleic acids and polynucleotides; polyguanylate (poly G) is the most effective. DNA and poly G also effectively restore the progesterone-binding ability of the ammonium sulfate-purified receptor which had been lost due to heat inactivation. After incubation of the unoccupied receptor from 5-30 min at 25 C, the addition of poly G restored the receptor's [3H]progesterone-binding ability to control levels. These data suggest that the progesterone receptor's steroid-binding site is more readily inactivated by heat than is the DNA-binding site, and that nucleic acid binding induces a conformational change, which consequently restores the receptor's progesterone-binding site to functional activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6705733     DOI: 10.1210/endo-114-4-1173

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Thermodynamic analysis of progesterone receptor-promoter interactions reveals a molecular model for isoform-specific function.

Authors:  Keith D Connaghan-Jones; Aaron F Heneghan; Michael T Miura; David L Bain
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-02       Impact factor: 11.205

2.  Thermodynamic dissection of estrogen receptor-promoter interactions reveals that steroid receptors differentially partition their self-association and promoter binding energetics.

Authors:  Amie D Moody; Michael T Miura; Keith D Connaghan; David L Bain
Journal:  Biochemistry       Date:  2012-01-12       Impact factor: 3.162

Review 3.  From steroid receptors to cytokines: the thermodynamics of self-associating systems.

Authors:  Keith D Connaghan; Amie D Moody; James P Robblee; James R Lambert; David L Bain
Journal:  Biophys Chem       Date:  2011-04-27       Impact factor: 2.352

4.  Interaction of cycloalkanoprogesterones with mammalian progesterone receptor: binding of pregna-D'-pentaranes in the calf uterine cytosol.

Authors:  A Bhakta; M Herman; I S Levina; V K Moudgil
Journal:  Mol Cell Biochem       Date:  1993-08-25       Impact factor: 3.396

5.  Glucocorticoid receptor-promoter interactions: energetic dissection suggests a framework for the specificity of steroid receptor-mediated gene regulation.

Authors:  James P Robblee; Michael T Miura; David L Bain
Journal:  Biochemistry       Date:  2012-05-22       Impact factor: 3.162

6.  Occurrence of a 6S intermediate form of the progesterone receptor that is sensitive to ribonuclease.

Authors:  D J Lamb; P E Kima; D W Bullock
Journal:  Mol Cell Biochem       Date:  1987-01       Impact factor: 3.396

7.  Nonsteroidal antiestrogens and partial estrogens with prostatic tumor inhibiting activity.

Authors:  M R Schneider; R W Hartmann; F Sinowatz; W Amselgruber
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.